Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7878358rdf:typepubmed:Citationlld:pubmed
pubmed-article:7878358lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:7878358lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:7878358lifeskim:mentionsumls-concept:C0019266lld:lifeskim
pubmed-article:7878358pubmed:issue20lld:pubmed
pubmed-article:7878358pubmed:dateCreated1995-4-5lld:pubmed
pubmed-article:7878358pubmed:abstractTextAll cancers result from the accumulation of mutations of proto-oncogenes and tumor suppressor genes. Sporadic and familial colorectal cancers result from the accumulation of the following genes, in a relatively stereotyped chronological order: the tumor suppressor gene apc whose mutations are responsible for the familial adenomatous polyposis; the proto-oncogene K-ras which is mutated in 50% of large adenomas (> 1 cm) and adenocarcinomas; the tumor suppressor gene dcc; and the tumor suppressor gene p53 whose inactivation in a factor of bad prognosis. While some of them are induced by mutagens, others result from an instability of the genome. Two types of instability are observed in both sporadic and familial colorectal cancer. The first type, which is found in 25-50% of cases, appears as cytogenetic abnormalities with aneuploidy and allelic losses. The second type of instability is induced by mutations of the hMSH2 or hMLH1 genes which code for proteins involved in the mechanism of DNA repair.lld:pubmed
pubmed-article:7878358pubmed:languagefrelld:pubmed
pubmed-article:7878358pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7878358pubmed:citationSubsetFlld:pubmed
pubmed-article:7878358pubmed:statusMEDLINElld:pubmed
pubmed-article:7878358pubmed:monthDeclld:pubmed
pubmed-article:7878358pubmed:issn0035-2640lld:pubmed
pubmed-article:7878358pubmed:authorpubmed-author:PectorJ CJClld:pubmed
pubmed-article:7878358pubmed:authorpubmed-author:ESODAE C JEClld:pubmed
pubmed-article:7878358pubmed:authorpubmed-author:ParmaJJlld:pubmed
pubmed-article:7878358pubmed:authorpubmed-author:RavelingienNNlld:pubmed
pubmed-article:7878358pubmed:issnTypePrintlld:pubmed
pubmed-article:7878358pubmed:day15lld:pubmed
pubmed-article:7878358pubmed:volume44lld:pubmed
pubmed-article:7878358pubmed:ownerNLMlld:pubmed
pubmed-article:7878358pubmed:authorsCompleteYlld:pubmed
pubmed-article:7878358pubmed:pagination2694-9lld:pubmed
pubmed-article:7878358pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7878358pubmed:meshHeadingpubmed-meshheading:7878358-...lld:pubmed
pubmed-article:7878358pubmed:meshHeadingpubmed-meshheading:7878358-...lld:pubmed
pubmed-article:7878358pubmed:meshHeadingpubmed-meshheading:7878358-...lld:pubmed
pubmed-article:7878358pubmed:meshHeadingpubmed-meshheading:7878358-...lld:pubmed
pubmed-article:7878358pubmed:meshHeadingpubmed-meshheading:7878358-...lld:pubmed
pubmed-article:7878358pubmed:meshHeadingpubmed-meshheading:7878358-...lld:pubmed
pubmed-article:7878358pubmed:year1994lld:pubmed
pubmed-article:7878358pubmed:articleTitle[Genes, heredity and colorectal cancer].lld:pubmed
pubmed-article:7878358pubmed:affiliationCentre de Génétique, Hôpital Erasme, Université Libre de Bruxelles.lld:pubmed
pubmed-article:7878358pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7878358pubmed:publicationTypeEnglish Abstractlld:pubmed